Literature DB >> 20640467

Neuropsychological rehabilitation in adult multiple sclerosis.

F Mattioli1, C Stampatori, F Bellomi, R Capra, M Rocca, M Filippi.   

Abstract

Neuropsychological impairment affects 40-65% of multiple sclerosis patients, mainly involving speed in information processing, attention, executive functions and memory. Deterioration occurs over time independently from disability and seems to correlate particularly with magnetic resonance imaging (MRI) atrophy measures. Studies on therapies effective in controlling cognitive impairment are scanty. We found that intensive and specific training of attention, information processing and executive functions is significantly effective in ameliorating both neuropsychological treated functions and in reducing depression. Preliminary functional MRI data suggest that possible neural correlates of this neuropsychological training could be an exercise-induced activation of prefrontal and cingulate cortices.

Entities:  

Mesh:

Year:  2010        PMID: 20640467     DOI: 10.1007/s10072-010-0373-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  19 in total

1.  Intensity of aphasia therapy, impact on recovery.

Authors:  Sanjit K Bhogal; Robert Teasell; Mark Speechley
Journal:  Stroke       Date:  2003-03-20       Impact factor: 7.914

Review 2.  Cognitive impairment in multiple sclerosis.

Authors:  F Patti
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

Review 3.  Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI.

Authors:  Iris-Katharina Penner; Ludwig Kappos; Martin Rausch; Klaus Opwis; Ernst W Radü
Journal:  J Physiol Paris       Date:  2006-05-19

4.  Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale.

Authors:  S A Rigby; C Domenech; E W Thornton; S Tedman; C A Young
Journal:  Mult Scler       Date:  2003-02       Impact factor: 6.312

5.  Thalamic atrophy and cognition in multiple sclerosis.

Authors:  M K Houtchens; R H B Benedict; R Killiany; J Sharma; Z Jaisani; B Singh; B Weinstock-Guttman; C R G Guttmann; R Bakshi
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

6.  Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial.

Authors:  Alessandra Solari; Achille Motta; Laura Mendozzi; Eugenio Pucci; Marco Forni; Gianluigi Mancardi; Carlo Pozzilli
Journal:  J Neurol Sci       Date:  2004-07-15       Impact factor: 3.181

7.  A prospective study of depression and immune dysregulation in multiple sclerosis.

Authors:  F W Foley; U Traugott; N G LaRocca; C R Smith; K R Perlman; L S Caruso; L C Scheinberg
Journal:  Arch Neurol       Date:  1992-03

8.  Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis.

Authors:  Flavia Mattioli; Mattioli Flavia; Chiara Stampatori; Deborah Zanotti; Giovanni Parrinello; Ruggero Capra
Journal:  J Neurol Sci       Date:  2009-10-13       Impact factor: 3.181

Review 9.  Cognitive impairment in multiple sclerosis.

Authors:  Nancy D Chiaravalloti; John DeLuca
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

10.  Group psychotherapy: benefits in multiple sclerosis.

Authors:  J D Crawford; G P McIvor
Journal:  Arch Phys Med Rehabil       Date:  1985-12       Impact factor: 3.966

View more
  13 in total

Review 1.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

2.  A randomized trial of cognitive rehabilitation in cancer survivors.

Authors:  M M Cherrier; K Anderson; D David; C S Higano; H Gray; A Church; S L Willis
Journal:  Life Sci       Date:  2013-09-05       Impact factor: 5.037

3.  Cognition and physical disability in predicting health-related quality of life in multiple sclerosis.

Authors:  Marietta Hoogs; Sukhmit Kaur; Audrey Smerbeck; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Int J MS Care       Date:  2011

Review 4.  Physical activity and cognitive function in adults with multiple sclerosis: an integrative review.

Authors:  Janet D Morrison; Lori Mayer
Journal:  Disabil Rehabil       Date:  2016-10-20       Impact factor: 3.033

5.  A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.

Authors:  M Huiskamp; E Dobryakova; G D Wylie; J DeLuca; N D Chiaravalloti
Journal:  Mult Scler Relat Disord       Date:  2016-03-24       Impact factor: 4.339

6.  The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.

Authors:  D Obradovic; M Petrovic; I Antanasijevic; J Marinkovic; T Stojanovic; S Obradovic
Journal:  Neurol Sci       Date:  2012-05-03       Impact factor: 3.307

7.  The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease: an exploratory study.

Authors:  Travis M Cruickshank; Jennifer A Thompson; Juan F Domínguez D; Alvaro P Reyes; Mike Bynevelt; Nellie Georgiou-Karistianis; Roger A Barker; Mel R Ziman
Journal:  Brain Behav       Date:  2015-01-15       Impact factor: 2.708

8.  Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.

Authors:  Martina Hubacher; Ludwig Kappos; Katrin Weier; Markus Stöcklin; Klaus Opwis; Iris-Katharina Penner
Journal:  Front Neurol       Date:  2015-04-08       Impact factor: 4.003

Review 9.  Clinical implications of neuroplasticity - the role of rehabilitation in multiple sclerosis.

Authors:  Peter Flachenecker
Journal:  Front Neurol       Date:  2015-03-03       Impact factor: 4.003

10.  Acceptance of the extracare program by Beta interferon-treated patients with multiple sclerosis: results of the explore study.

Authors:  Matthias Freidel; Sonja Ortler; Alexander Fuchs; Sabine Seibert; Katrin Schuh
Journal:  J Neurosci Nurs       Date:  2015-02       Impact factor: 1.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.